Scabies

Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers

National Study on the Epidemiology and Effectiveness of Therapies in the Treatment of Scabies

Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)

HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation

Comparison of Permethrin-Based Treatment Strategies Against Scabies in Infants and Young Children

Evaluating Pediatric Ivermectin in Children Under 15 kg (EPIC-15)

Ivermectin Safety in Small Children

Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases

Better Options for Lymphatic Filariasis Treatment

Efficacy and Safety Study of Moxidectin in Adults With Scabies

Comparison of Permethrin and Ivermectin in Children Greater Than 6 Yrs Age for Treatment of Scabies

PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies

Sensitivity of Self-collected Skin Sampling for Scabies: a Pilot Study

Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults

Sulfur vs. Different Regimes of Permethrin for Scabies

Therapy for Scabies With Two Differently Concentrated Permethrin Creams

Dose-finding Study of Moxidectin for Treatment of Scabies

Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of Scabies

A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies

Ivermectin/ Permethrin for Scabies